These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 38836394)
1. [Sexual health in female under treatment for opiate dependence using diacetylmorphine]. Khatcherian E; Soulignac R; Zullino D; Achab S Rev Med Suisse; 2024 Jun; 20(877):1115-1118. PubMed ID: 38836394 [TBL] [Abstract][Full Text] [Related]
2. Quality of life under maintenance treatment with heroin versus methadone in patients with opioid dependence. Karow A; Reimer J; Schäfer I; Krausz M; Haasen C; Verthein U Drug Alcohol Depend; 2010 Dec; 112(3):209-15. PubMed ID: 20728288 [TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of hydromorphone for severe opioid use disorder: findings from the SALOME randomized clinical trial. Bansback N; Guh D; Oviedo-Joekes E; Brissette S; Harrison S; Janmohamed A; Krausz M; MacDonald S; Marsh DC; Schechter MT; Anis AH Addiction; 2018 Jul; 113(7):1264-1273. PubMed ID: 29589873 [TBL] [Abstract][Full Text] [Related]
4. Characteristics and response to treatment among Indigenous people receiving injectable diacetylmorphine or hydromorphone in a randomised controlled trial for the treatment of long-term opioid dependence. Oviedo-Joekes E; Palis H; Guh D; Marchand K; Brissette S; Lock K; MacDonald S; Harrison S; Anis AH; Krausz M; Marsh DC; Schechter MT Drug Alcohol Rev; 2018 Jan; 37(1):137-146. PubMed ID: 28593748 [TBL] [Abstract][Full Text] [Related]
6. Double-blind injectable hydromorphone versus diacetylmorphine for the treatment of opioid dependence: a pilot study. Oviedo-Joekes E; Guh D; Brissette S; Marsh DC; Nosyk B; Krausz M; Anis A; Schechter MT J Subst Abuse Treat; 2010 Jun; 38(4):408-11. PubMed ID: 20359843 [TBL] [Abstract][Full Text] [Related]
7. Can Treatment for Substance Use Disorder Prescribe the same Substance as that Used? The Case of Injectable Opioid Agonist Treatment. Steel D; Tekin Ş Kennedy Inst Ethics J; 2021; 31(3):271-301. PubMed ID: 34565745 [TBL] [Abstract][Full Text] [Related]
8. Effectiveness of diacetylmorphine versus methadone for the treatment of opioid dependence in women. Oviedo-Joekes E; Guh D; Brissette S; Marchand K; Marsh D; Chettiar J; Nosyk B; Krausz M; Anis A; Schechter MT Drug Alcohol Depend; 2010 Sep; 111(1-2):50-7. PubMed ID: 20510551 [TBL] [Abstract][Full Text] [Related]
9. The suitability of oral diacetylmorphine in treatment-refractory patients with heroin dependence: A scoping review. F Martins ML; Wilthagen EA; Oviedo-Joekes E; Beijnen JH; de Grave N; Uchtenhagen A; Beck T; Van den Brink W; Schinkel AH Drug Alcohol Depend; 2021 Oct; 227():108984. PubMed ID: 34482044 [TBL] [Abstract][Full Text] [Related]
10. Hydromorphone Compared With Diacetylmorphine for Long-term Opioid Dependence: A Randomized Clinical Trial. Oviedo-Joekes E; Guh D; Brissette S; Marchand K; MacDonald S; Lock K; Harrison S; Janmohamed A; Anis AH; Krausz M; Marsh DC; Schechter MT JAMA Psychiatry; 2016 May; 73(5):447-55. PubMed ID: 27049826 [TBL] [Abstract][Full Text] [Related]
11. Controlled trial of prescribed heroin in the treatment of opioid addiction. March JC; Oviedo-Joekes E; Perea-Milla E; Carrasco F; J Subst Abuse Treat; 2006 Sep; 31(2):203-11. PubMed ID: 16919749 [TBL] [Abstract][Full Text] [Related]
12. Pharmacological treatments of opiate dependence. Benyamina A; Reynaud M; Blecha L; Karila L Curr Pharm Des; 2011; 17(14):1384-8. PubMed ID: 21524267 [TBL] [Abstract][Full Text] [Related]
13. Heroin-assisted treatment as a response to the public health problem of opiate dependence. Fischer B; Rehm J; Kirst M; Casas M; Hall W; Krausz M; Metrebian N; Reggers J; Uchtenhagen A; van den Brink W; van Ree JM Eur J Public Health; 2002 Sep; 12(3):228-34. PubMed ID: 12232964 [TBL] [Abstract][Full Text] [Related]
14. History of reported sexual or physical abuse among long-term heroin users and their response to substitution treatment. Oviedo-Joekes E; Marchand K; Guh D; Marsh DC; Brissette S; Krausz M; Anis A; Schechter MT Addict Behav; 2011; 36(1-2):55-60. PubMed ID: 20855171 [TBL] [Abstract][Full Text] [Related]
15. Slow-release oral morphine as maintenance therapy for opioid dependence. Ferri M; Minozzi S; Bo A; Amato L Cochrane Database Syst Rev; 2013 Jun; (6):CD009879. PubMed ID: 23740540 [TBL] [Abstract][Full Text] [Related]
16. Association of nerve growth factor and vascular endothelial growth factor A with psychometric measurements of opiate dependence: results of a pilot study in patients participating in a structured diamorphine maintenance program. Heberlein A; Dürsteler-MacFarland KM; Frieling H; Gröschl M; Lenz B; Bönsch D; Kornhuber J; Wiesbeck GA; Bleich S; Hillemacher T Eur Addict Res; 2012; 18(5):213-9. PubMed ID: 22517242 [TBL] [Abstract][Full Text] [Related]
17. Behavioral drug and HIV risk reduction counseling (BDRC) in MMT programs in Wuhan, China: a pilot randomized clinical trial. Chawarski MC; Zhou W; Schottenfeld RS Drug Alcohol Depend; 2011 Jun; 115(3):237-9. PubMed ID: 21159452 [TBL] [Abstract][Full Text] [Related]
18. Safety profile of injectable hydromorphone and diacetylmorphine for long-term severe opioid use disorder. Oviedo-Joekes E; Brissette S; MacDonald S; Guh D; Marchand K; Jutha S; Harrison S; Janmohamed A; Zhang DZ; Anis AH; Krausz M; Marsh DC; Schechter MT Drug Alcohol Depend; 2017 Jul; 176():55-62. PubMed ID: 28521199 [TBL] [Abstract][Full Text] [Related]